Steroid Exposure, Acute Coronary Syndrome, and Inflammatory Bowel Disease: Insights into the Inflammatory Milieu Pearl Zakroysky, MPH, Wai-ee Thai, MD, Roderick C. Deaño, MD, MPH, Sandeep Basnet, MD, Zurine Galvan Onandia, MD, Sachin Gandhi, MD, Ahmed Tawakol, MD, James K. Min, MD, Quynh A. Truong, MD, MPH The American Journal of Medicine Volume 128, Issue 3, Pages 303-311 (March 2015) DOI: 10.1016/j.amjmed.2014.10.033 Copyright © 2015 Elsevier Inc. Terms and Conditions
Figure 1 Study schema and population. The American Journal of Medicine 2015 128, 303-311DOI: (10.1016/j.amjmed.2014.10.033) Copyright © 2015 Elsevier Inc. Terms and Conditions
Figure 2 Association between acute coronary syndrome and steroid exposure among patients with inflammatory bowel disease and by inflammatory bowel disease type. For inflammatory bowel disease, adjusted analysis included body mass index, diabetes, dyslipidemia, smoking, family history of coronary artery disease, white blood count and aspirin. For Crohn's disease, adjusted analysis included body mass index, white blood count, and dyslipidemia. For ulcerative colitis, adjusted analysis included body mass index, diabetes, smoking, family history of coronary artery disease, and aspirin. The American Journal of Medicine 2015 128, 303-311DOI: (10.1016/j.amjmed.2014.10.033) Copyright © 2015 Elsevier Inc. Terms and Conditions